From the October 2021 issue of HealthCare Business News magazine


“There are no support structures underneath that can get in the way of the beam,” said Emilie Cuypers, product manager for radiation oncology at Orfit.

Aerial can be used with IBA, Mevion and Varian proton therapy systems.


Orfit’s HP PRO thermoplastic mask system, for use in immobilization when treating brain, head and neck cancers, is integrated into Aerial, attaching to an extension of the couch top.

Also in 2020, Orfit released the third generation of its All-in-One patient positioning system, a carbon fiber base plate combined with positioning cushions that index on top of the treatment table for general radiation therapy.

The newly designed AIO Solution 3.0 positions patients using cushions that are made from a comfortable foam. The cushions withstand rough handling conditions, and the integration of handles, clicking instead of screwing materials to fix on the base plate, and lightweight materials make the cushions ergonomic.

ProTom International
The Gordon-Browne Proton Therapy Center at Massachusetts General Hospital has been treating patients with ProTom’s single-room Radiance 330 Proton Therapy System since February 2020. This is a single-room version of the Radiance 330, though ProTom also has the capability to provide multi-treatment room and expandable configurations.

ProTom is also actively pursuing imaging with protons, a technology that will allow improvements in proton treatment planning and implementation, said Stephen Spotts, chief executive officer of ProTom International.

"Radiance 330 is the only proton therapy system that is capable of proton imaging any anatomical location in a patient," Spotts said. "With clinical treatment energy range of 70 MeV to 250 MeV and the ability to accelerate protons up to 330 MeV, the Radiance 330 is capable of treating and imaging with the same beam."

ProTom plans to continue working with its system users, collaborating in the advancement of proton tomography and radiography, Spotts said.

"We will also continue to strive to further reduce the cost of our system, so any radiation oncology practice or hospital can afford an advanced proton therapy system," Spotts said.

While ProTom expands within the U.S. market, the company is also actively developing an overseas market, with customers in Australia and a distribution agreement in place to expand sales of Radiance 330 into China.

The company is moving forward with installation of a Radiance 330 proton therapy system at the new Australian Bragg Centre in Adelaide. This will be the first proton therapy center in Australia and the Southern Hemisphere, and is expected to begin operating in early 2024.

October 2021 Magazine

Read more stories from the October 2021 issue

More Magazine Features

Rad Oncology Homepage